T
Translational Development Acquisition Corp
NASDAQ:TDAC
Translational Development Acquisition Corp
NASDAQ:TDAC
Price:
10.54
USD
Market Closed
Market Cap:
$230.9m
Relative Value
There is not enough data to reliably calculate the relative value of TDAC.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TDAC
Relative Value
Base Case
Not Available
Multiples Across Competitors
TDAC Competitors Multiples
Translational Development Acquisition Corp Competitors
Translational Development Acquisition Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
230.9m USD | 0 | 48.5 | -252.2 | -252.2 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
223B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
95.6B ZAR | 5.5 | 10.2 | 14 | 14.1 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.4B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
42.7B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.8B EUR | 1 | 165.3 | 30 | 62.8 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.7B USD | 12.8 | -2 818.9 | -3 698.9 | -594.3 | |
| US |
C
|
Circle Internet Group Inc
NYSE:CRCL
|
30.5B USD | 0 | 0 | 0 | 0 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
27.9B ZAR | 5.2 | 6.4 | 16.8 | 16.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
